<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): June 19, 2000
Inamed Corporation
------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
Delaware 001-09741 59-0920629
-------------------------------------------------------------------------------
(State or Other Juris- (Commission File (IRS Employer
diction of Incorporation) Number) Identification No.)
5540 Ekwill Street - Suite D, Santa Barbara, California 93111-2919
------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number: (805) 692-5400
N/A
------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
<PAGE> 2
Item 5. Other Events.
On June 19, 2000, the Registrant issued a press release announcing
that an FDA advisory panel on gastroenterology and urology devices voted 6-4
to recommend FDA rejection of the Premarket Approval Application (PMA) for the
LAP-BAND(R) System for obesity treatment. The Registrant's press release
dated June 19, 2000 is attached.
Item 7. Financial Statements and Exhibits.
(a) Financial Statements
Not Applicable
(b) Pro Forma Financial Information
Not Applicable
(c) Exhibits
99.1 Press Release dated June 19, 2000.
2
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
INAMED CORPORATION
Date: June 23, 2000 By: /s/ David E. Bamberger
-----------------------------------------
Name: David E. Bamberger
Title: Senior Vice President, Secretary
and General Counsel
3
